Physician profile
Bao G Tran
NPI 1104065440
$129,924.24
in general payments reported to CMS, 2019-2025
72 companies · $29K in 2025
The $29K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $4,117 · 2021: $9,700 · 2022: $9,139 · 2023: $16K · 2024: $35K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $20K · Food and Beverage: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $14K · Consulting Fee: $11K · Education: $40.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $19,500.00 |
| Food and Beverage | $18,659.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,425.00 |
| Travel and Lodging | $13,984.84 |
| Consulting Fee | $11,311.00 |
| Education | $40.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $25,180.31 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $21,021.75 | 2023-2024 | Inpefa |
| Medtronic, INC. | $11,195.36 | 2021-2025 | Resolute Onyx, Onyx Frontier, Endurant Iis |
| Medtronic Vascular, INC. | $10,652.32 | 2019-2020 | |
| Abbott Laboratories | $9,425.60 | 2019-2025 | Cardiomems, Ionicrf, Jot Dx |
| Janssen Pharmaceuticals, INC | $7,310.06 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $6,651.29 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Comet |
| Cathworks, INC. | $5,015.03 | 2019-2024 | Ffrangio |
| Astrazeneca Pharmaceuticals LP | $2,621.14 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Amgen INC. | $2,312.95 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,294.37 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $2,066.43 | 2019-2025 | |
| Penumbra, INC. | $1,963.81 | 2019-2023 | Indigo System, Penumbra System |
| Recor Medical INC | $1,683.22 | 2024 | Paradise Renal Denervation System |
| Cardiovascular Systems INC. | $1,487.73 | 2019-2023 | Diamondback Coronary |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,383.67 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $1,254.41 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $1,231.06 | 2019-2024 | |
| Esperion Therapeutics, INC. | $1,199.52 | 2020-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $1,122.99 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,039.53 | 2019-2025 | Lifevest |
| Pfizer INC. | $973.12 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $900.62 | 2021-2025 | Opsumit, Uptravi |
| Becton, Dickinson and Company | $887.53 | 2021-2024 | Venclose Maven Catheter |
| Inari Medical, INC. | $859.94 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $797.46 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $691.58 | 2022-2023 | Optimizer |
| Amarin Pharma, INC. | $640.82 | 2019-2021 | |
| Chiesi USA, INC. | $590.72 | 2020-2024 | Kengreal, Cleviprex |
| Edwards Lifesciences Corporation | $525.49 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Bardy Diagnostics, INC. | $460.33 | 2020-2022 | |
| Abiomed | $429.02 | 2020-2025 | Impella |
| Vertex Pharmaceuticals Incorporated | $413.33 | 2021 | |
| Biotronik INC. | $361.88 | 2023 | Biomonitor |
| Irhythm Technologies, INC. | $333.93 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $314.22 | 2023-2025 | Amvuttra, Onpattro |
| Scpharmaceuticals INC. | $258.57 | 2023-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $215.58 | 2021-2023 | Arcalyst |
| Baxter Healthcare | $214.10 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Perclot, Hillrom - Cardiac Ambulatory Monitor |
| Cvrx, INC. | $176.68 | 2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $157.52 | 2024 | Assure Wcd |
| Vifor Pharma, INC. | $118.80 | 2019 | |
| United Therapeutics Corporation | $111.61 | 2019 | |
| Heartflow, INC. | $109.33 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $100.23 | 2019 | |
| Philips North America LLC | $98.23 | 2023-2025 | (5044) Mcot, Mcot |
| Kiniksa Pharmaceuticals International, Plc | $94.08 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $92.55 | 2021 | |
| Seigla Medical, INC. | $86.43 | 2024 | |
| Lilly USA, LLC | $73.61 | 2025 | Zepbound, Mounjaro |
| Astellas Pharma US INC | $72.70 | 2020-2021 | |
| Lundbeck LLC | $63.53 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $62.67 | 2021-2022 | |
| Itamar Medical INC | $56.26 | 2023 | Watchpatone |
| Agepha Pharma Fz LLC | $38.76 | 2025 | Lodoco |
| Angiodynamics, INC. | $38.29 | 2021 | |
| Endotronix, INC. | $38.09 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Atricure, INC. | $36.95 | 2024 | |
| Stryker Corporation | $31.40 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cleerly, INC. | $27.96 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Elutia, INC. | $27.18 | 2019 | |
| Osprey Medical INC | $25.00 | 2019 | |
| Avinger INC. | $24.79 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.15 | 2019 | |
| Terumo Medical Corporation | $23.32 | 2019 | |
| Bridgebio Pharma, INC. | $22.66 | 2025 | Attruby |
| Teva Pharmaceuticals USA, INC. | $20.98 | 2021 | |
| Azurity Pharmaceuticals, INC. | $19.35 | 2025 | Alvesco |
| Sandoz INC. | $18.53 | 2019 | |
| Octapharma USA, INC. | $18.18 | 2025 | Balfaxar |
| Cordis US Corp. | $17.47 | 2025 | Mynx Control Venous |
| Tactile Systems Technology INC | $16.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bao Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.